BPC 157 upregulates VEGFR2 expression in rats with hind limb ischemia and in endothelial cell culture
Earlier oral trial METAOD005 randomized 300 adults with obesity to oral AOD-9604 (1, 5, 10, 20, or 30 mg/day) or placebo for 12 weeks
Roughly 80 people have received BPC-157 across five published studies
Rare adverse events that might emerge in large studies could remain invisible in community discussions
PureRawz has been in this market since 2017, operating with a catalog of over 100 research-grade compounds (peptides, SARMs, nootropics, and GLP-1 agents), each backed by batch-specific Certificates of Analysis from an independent third-party laboratory
Eur J Drug Metab Pharmacokinet (2006) 31(2):10916